Differential requirement for CD4 help in the development of an antigen- specific CD8+ T cell response depending on the route of immunization

Journal of Immunology

Volumn 160, Issue 11, 1998, Pages 5522-5529

  Bour, Hélène ^a   Horvath, Clotilde ^a   Lurquin, Christophe ^b   Cerottini, Jean Charles ^a   Robson MacDonald, H ^a,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GENE PRODUCT; HLA C ANTIGEN; T LYMPHOCYTE ANTIGEN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNIZATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; HELPER CELL; HLA SYSTEM; INTRADERMAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL; TUMOR REJECTION;

ADOPTIVE TRANSFER; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; GENES, MHC CLASS I; HLA-C ANTIGENS; IMMUNOLOGIC MEMORY; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAPERITONEAL; KINETICS; L-SELECTIN; LYMPHOCYTE ACTIVATION; MAST-CELL SARCOMA; MICE; MICE, INBRED DBA; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032103038     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Melief, C. J. 1992. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res. 58:143.
2. Boon, T., J.-C. Cerottini, B. Van den Eynde, P. Van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337.
3. Rees, M. A., A. S. Rosenberg, T. I. Munitz, and A. Singer. 1990. In vivo induction of antigen-specific transplantation tolerance to Qa1a by exposure to alloantigen in the absence of T-cell help. Proc. Natl. Acad. Sci. USA 87:2765.
4. Guerder, S., and P. Matzinger. 1992. A fail-safe mechanism for maintaining self-tolerance. J. Exp. Med. 176:553.
5. + T cell help. J. Exp. Med. 186:65.
6. Buller, R. M., K. L. Holmes, A. Hugin, T. N. Frederickson, and H. C. Morse III. 1987. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 328:77.
7. + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62:2102.
8. + T cell lineage to mount an effective tumoricidal response to syngeneic tumor-bearing novel class I MHC antigens. J. Immunol. 143:4287.
9. Ellenhorn, J. D. I., H. Schreiber, and J. A. Bluestone. 1990. Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice. J. Immunol. 144:2840.
10. + T cells by B7-transfected melanoma cells. Science 259:368.
11. Ljunggren, G., H.-G. Ljunggren, and T. Dalianis. 1994. T cell subsets involved in immunity against polyoma virus-induced tumors. Virology 198:714.
12. + T lymphocytes. J. Immunol. 156:3919.
13. MacDonald, H. R., J. L. Casanova, J. L. Maryanski, and J.-C. Cerottini. 1993. Oligoclonal expansion of major histocompatibility complex class I-restricted cytolytic T lymphocytes during a primary immune response in vivo: direct monitoring by flow cytometry and polymerase chain reaction. J. Exp. Med. 177:1487.
14. Walker, P. R., T. Ohteki, J. A. Lopez, H. R. MacDonald, and J. L. Maryanski. 1995. Distinct phenotypes of antigen-selected CD8 T cells emerge at different stages of an in vivo immune response. J. Immunol. 155:3443.
15. Maryanski, J. L., C. V. Jongeneel, P. Bucher, J.-L. Casanova, and P. R. Walker. 1996. Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. Immunity 4:47.
16. Maryanski, J. L., R. S. Accolla, and B. Jordan. 1986. H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells. J. Immunol. 136:4340.
17. Takebe, Y., M. Seiki, J. Fujisawa, P. Hoy, K. Yokota, K. Arai, M. Yoshida, and N. Arai. 1988. SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8:466.
18. Graham, F. L., and A. J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456.
19. Wigler, M., A. Pellicer, S. Silverstein, and R. Axel. 1978. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell 14:725.
20. Nicolas, J. F., and P. Berg. 1983. In Teratocarcmoma Stem Cells, Vol. 10. L. M. Silver, G. R. Martin, and S. Strickland, eds. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, p. 469.
21. Casanova, J. L., J. C. Cerottini, M. Matthes, A. Necker, H. Gournier, C. Barra, C. Widmann, H. R. MacDonald, F. Lemonnier, B. Malissen, and J. L. Maryanski. 1992. H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity. J. Exp. Med. 176:439.
22. Brunner, K. T., H. R. MacDonald, and J.-C. Cerottini. 1980. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells. J. Immunol. 124:1627.
23. Huang, A. Y. C., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961.
24. Huang, A. Y. C., A. T. Bruce, D. M. Pardoll, and H. I. Levitsky. 1996. Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? J. Exp. Med. 183:769.
25. Beller, D. I., J. M. Kiely, and E. R. Unanue. 1980. Regulation of macrophage populations. I. Preferential induction of Ia-rich peritoneal exudates by immunologic stimuli. J. Immunol. 124:1426.
26. Walker, E. B., L. L. Lanier, and N. L. Warner. 1982. Concomitant induction of the cell surface expression of Ia determinants and accessory cell function by a murine macrophage tumor cell line. J. Exp. Med. 155:629.
27. Mackey, M. F., J. R. Gunn, P. P. Ting, H. Kikutani, G. Dranoff, R. J. Noelle, and R. J. Barth, Jr. 1997. Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154. Cancer Res. 57:2569.
28. + cytotoxic T lymphocytes by dendritic cells. J. Exp. Med. 166:182.
29. Mayordomo, J. I., T. Zorina, W. J. Storkus, L. Zitvogel, C. Celluzi, L. D. Falo, C. J. Melief, S. T. Ildstad, W. M. Kast, A. B. Deleo, and M. T. Lotze. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1:1297.
30. + effector T cells during progressive growth of the P815 masiocytoma. Immunology 54:47.
31. + T suppressor cells in mice rendered unresponsive to tumor antigens by intravenous injection of irradiated tumor cells. Int. J. Cancer 55:339.
32. Kumar, V., K. Sellrecht, and E. Sercarz. 1996. Inactivation of T cell receptor peplide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). J. Exp. Med. 184:1607.
33. Mombaerts, P., E. Mizoguchi, M. J. Grusby, L. H. Glimcher, A. K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T eell receptor mutant mice. Cell 75:274.
34. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737.
35. + T cells respectively mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur. J. Immunol. 25:3006.
36. + cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system. Proc. Natl. Acad. Sci. USA 93:10399.
37. Chen, L., S. Ashe, W. A. Brady, I. Hellström, K. E. Hellström, J. A. Ledbetter, P. MacGowan, and P. S. Linsley. 1992. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093.
38. Cavallo, F., A. Martin-Fontecha, M. Bellone, S. Heltai, E. Gatti, P. Tomaghi, M. Freschi, G. Forni, P. Dellabona, and G. Casorati. 1995. Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur. J. Immunol. 25:1154.
39. Yang, G., K. E. Hellström, I. Hellström, and L. Chen. 1995. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J. Immunol. 154:2794.
40. Rakhmilevich, A. L., J. Turner, M. J. Ford, D. McCabe, W. H. Sun, P. M. Sondel, K. Grota, and N. S. Yang. 1996. Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc. Natl. Acad. Sci. USA 93:6291.
41. Song, W., H. L. Kong, H. Carpenter, H. Torii, R. Graustein, S. Rafii, M. A. S. Moore, and R. G. Crystal. 1997. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J. Exp. Med. 186:1247.